Alerta De Seguridad para CREATININA - Registered in Anvisa under the number 80115310057 - Lots: 1073230945 (Creatinine R1 2x200ml + R2 1x100ml + 1x3ml Standard) and 1070890942 (Creatinine R1 1x200ml + R2 1x50ml + 1x3ml Standard) - Kovalent do Brasil Ltda.

Según Agência Nacional de Vigilância Sanitária (ANVISA), este evento ( alerta de seguridad ) involucró a un dispositivo médico en Brazil que fue producido por Kovalent do Brasil Ltda..

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • ID del evento
    972
  • Fecha
    2009-07-24
  • País del evento
  • Fuente del evento
    ANVISA
  • URL de la fuente del evento
  • Notas / Alertas
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Notas adicionales en la data
    It is important to note that clinical laboratories use controls capable of identifying this type of quality deviation, since changes in creatinine levels may indicate renal impairment. By means of the traceability of the affected lots, the communication was made to the customers (see annex), informing them of the fact. The process of collecting the lots is already underway and Anvisa follows the process. ### The company informed the closing of the field action through file 842387 / 09-3 of 10/27/2009.
  • Causa
    By means of studies carried out by the manufacturer, the loss of stability in a specific lot of the raw material dissodiohydrogen-phosphate, causing a decrease of stability in the creatine reagent, has been identified, being able to lead to falsely low results.
  • Acción
    The actions recommended to users of the product are as follows: (1) Immediate discontinuation of use and segregation of the affected product set forth in this notice; (2) Contact your dealer or distributor (see attached list)

Manufacturer